{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T17:57:40Z","timestamp":1759773460721},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1475-2875-9-s3-s1","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T16:14:00Z","timestamp":1297181640000},"source":"Crossref","is-referenced-by-count":10,"title":["Is vaccine the magic bullet for malaria elimination? A reality check"],"prefix":"10.1186","volume":"9","author":[{"given":"Roma","family":"Chilengi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Gitaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,13]]},"reference":[{"key":"1577_CR1","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1172\/JCI33996","volume":"118","author":"BM Greenwood","year":"2008","unstructured":"Greenwood BM, Fidock DA, Kyle DE, Kappe SHI, Alonso PL: Malaria: progress, perils, and prospects for eradication. J Clin Invest. 2008, 118: 1266-1276. 10.1172\/JCI33996.","journal-title":"J Clin Invest"},{"key":"1577_CR2","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1371\/journal.pmed.0020330","volume":"2","author":"KI Barnes","year":"2005","unstructured":"Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL: Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med. 2005, 2: e330-10.1371\/journal.pmed.0020330.","journal-title":"PLoS Med"},{"key":"1577_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1475-2875-5-33","volume":"5","author":"PM Nyarango","year":"2006","unstructured":"Nyarango PM, Gebremeskel T, Mebrahtu G, Mufundu J, Abdulmumini U, Ogbamariam A, Kosia A, Gebremichael A, Gunawardena D, Ghebrat Y, Okbaldet Y: A steep decline of malaria morbidity and mortality trends in Eritrea between 2000 and 2004: the effect of combination of control methods. Malar J. 2006, 5: 33-10.1186\/1475-2875-5-33.","journal-title":"Malar J"},{"key":"1577_CR4","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1371\/journal.pmed.0040309","volume":"4","author":"A Bhattarai","year":"2007","unstructured":"Bhattarai A, Abdullah SA, Kachur SP, Martensson A, Abbas AK, Khatib R, Abdul A, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S, Montgomery SM, Kaneko A, Bjorkman A: Impact of artemisinin based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 2007, 4: e309-10.1371\/journal.pmed.0040309.","journal-title":"PLoS Med"},{"key":"1577_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature03342","volume":"434","author":"RW Snow","year":"2005","unstructured":"Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005, 434: 214-217. 10.1038\/nature03342.","journal-title":"Nature"},{"key":"1577_CR6","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/S0140-6736(05)66420-3","volume":"365","author":"BM Greenwood","year":"2005","unstructured":"Greenwood BM, Bojang K, Whitty CJM, Targett GAT: Malaria. Lancet. 2005, 365: 1487-1498. 10.1016\/S0140-6736(05)66420-3.","journal-title":"Lancet"},{"key":"1577_CR7","first-page":"624","volume":"77","author":"RW Snow","year":"1999","unstructured":"Snow RW, Craig M, Deichmann U, Marsh K: Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ. 1999, 77: 624-640.","journal-title":"Bull World Health Organ"},{"key":"1577_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/415694a","volume":"415","author":"TL Richie","year":"2002","unstructured":"Richie TL, Saul A: Progress and challenges for malaria vaccines. Nature. 2002, 415: 694-701. 10.1038\/415694a.","journal-title":"Nature"},{"key":"1577_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-3024.2009.01140.x","volume":"31","author":"B Greenwood","year":"2009","unstructured":"Greenwood B, Targett G: Do we still need a malaria vaccine?. Parasite Immunol. 2009, 31: 582-586. 10.1111\/j.1365-3024.2009.01140.x.","journal-title":"Parasite Immunol"},{"key":"1577_CR10","unstructured":"Arnot D: Malaria vaccines: research problems and priorities. Accessed 27th September 2010, [ http:\/\/www.scidev.net\/en\/health\/malaria\/policy-briefs\/malaria-vaccines-research-problems-and-priorities.html ]"},{"key":"1577_CR11","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa0807381","volume":"359","author":"P Bejon","year":"2008","unstructured":"Bejon P, Lusingu J, Olotu A, Leach A, Lievens M, Vekemans J, Vekemans Johan, Salum Mshamu, Trudie Lang, Jayne Gould, Marie-Claude Dubois, Marie-Ange Demoiti\u00e9, Jean-Francois Stallaert, Preeti Vansadia, Terrell Carter, Patricia Njuguna, Ken Awuondo, Anangisye Malabeja, Omar Abdul, Samwel Gesase, Neema Mturi, Chris Drakeley, Barbara Savarese, Tonya Villafana, Ripley Ballou W, Joe Cohen, Eleanor Riley, Martha Lemnge, Kevin Marsh, Lorenz von Seidlein: Efficacy of RTS,S\/AS01E Vaccine against malaria in children 5 to 17 months of age. N Engl J Med. 2008, 359: 2521-32. 10.1056\/NEJMoa0807381.","journal-title":"N Engl J Med"},{"key":"1577_CR12","unstructured":"WHO: Informal consultation on malaria elimination: setting up the WHO agenda. WHO\/HTM\/MAL\/2006\/.1114."},{"key":"1577_CR13","first-page":"61","volume":"2","author":"I Brito","year":"2001","unstructured":"Brito I: Eradicating malaria: high hopes or a tangible goal?. Health Policy at Harvard. 2001, 2: 61-66.","journal-title":"Health Policy at Harvard"},{"key":"1577_CR14","unstructured":"Najera JA: Malaria control, achievements, problems and strategies. (WHO document No. MAL\/99.1087)."},{"key":"1577_CR15","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1086\/646613","volume":"200","author":"CV Plowe","year":"2009","unstructured":"Plowe CV, Alonso P, Hoffman SL: The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. J Infect Dis. 2009, 200: 1646-1649. 10.1086\/646613.","journal-title":"J Infect Dis"},{"key":"1577_CR16","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1371\/journal.pbio.0050042","volume":"5","author":"DL Smith","year":"2007","unstructured":"Smith DL, McKenzie FE, Snow RW, Hay SI: Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol. 2007, 5: e42-10.1371\/journal.pbio.0050042.","journal-title":"PLoS Biol"},{"key":"1577_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nri1746","volume":"6","author":"AVS Hill","year":"2006","unstructured":"Hill AVS: Pre-erythrocytic malaria vaccines: towards greater efficacy. Nature Reviews. 2006, 6: 21-32. 10.1038\/nri1746.","journal-title":"Nature Reviews"},{"issue":"Suppl.","key":"1577_CR18","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1017\/S0031182006001843","volume":"133","author":"T Richie","year":"2006","unstructured":"Richie T: High road, low road? Choices and challenges on the pathway to a malaria vaccine. Parasitology. 2006, 133 (Suppl.): S113-S144. 10.1017\/S0031182006001843.","journal-title":"Parasitology"},{"key":"1577_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1586\/14760584.5.1.81","volume":"5","author":"M Walther","year":"2006","unstructured":"Walther M: Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria. Expert Review Vaccines. 2006, 5: 81-93. 10.1586\/14760584.5.1.81.","journal-title":"Expert Review Vaccines"},{"key":"1577_CR20","unstructured":"WHO: Malaria Vaccine Rainbow Tables. Accessed 25th March 2010, [ http:\/\/www.who.int\/vaccine_research\/links\/Rainbow\/en\/index.html ]"},{"key":"1577_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1086\/339409","volume":"185","author":"SL Hoffman","year":"2002","unstructured":"Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, Vega P, Dowler M, Paul C, Gordon DM, Stoute JA, Church LWP, Sedegah M, Heppner DG, Ballou WR, Richie TL: Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002, 185: 1155-1164. 10.1086\/339409.","journal-title":"J Infect Dis"},{"key":"1577_CR22","first-page":"9","volume":"68","author":"DS Clyde","year":"1990","unstructured":"Clyde DS: Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies 1971-75. Bull World Health Organ. 1990, 68: 9-12.","journal-title":"Bull World Health Organ"},{"key":"1577_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0140-6736(07)61477-9","volume":"370","author":"GW Fegan","year":"2007","unstructured":"Fegan GW, Noor AM, Akhwale WS, Cousens S, Snow RW: Effect of expanded insecticide treated bednet coverage on child survival in rural Kenya: a longitudinal study. Lancet. 2007, 370: 1035-1039. 10.1016\/S0140-6736(07)61477-9.","journal-title":"Lancet"},{"key":"1577_CR24","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(95)90582-0","volume":"345","author":"U D\u2019Alessandro","year":"1995","unstructured":"D\u2019Alessandro U, Olaleye B, Langerock P, Aikins MK, Thomson MC, Cham MK, Greenwood BM, McGuire W, Bennett S, Cham MK, Cham BA: Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bed net programme. Lancet. 1995, 345: 479-483. 10.1016\/S0140-6736(95)90582-0.","journal-title":"Lancet"},{"key":"1577_CR25","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(00)04404-4","volume":"357","author":"JR Schellenberg","year":"2001","unstructured":"Schellenberg JR, Abdulla S, Nathan R, Mukasa O, Marchant TJ, Kikumbih N, Mushi AK, Mponda H, Minja H, Mshinda H, Tanner M, Lengeler C: Effect of large-scale social marketing of insecticide-treated nets on child survival in rural Tanzania. Lancet. 2001, 357: 1241-1247. 10.1016\/S0140-6736(00)04404-4.","journal-title":"Lancet"},{"key":"1577_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1475-2875-6-101","volume":"6","author":"SJ Moore","year":"2007","unstructured":"Moore SJ, Darling ST, Sihuincha M, Padilla N, Devine GJ: A low-cost repellent for malaria vectors in the Americas: results of two field trials in Guatemala and Peru. Malar J. 2007, 6: 101-10.1186\/1475-2875-6-101.","journal-title":"Malar J"},{"key":"1577_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa011699","volume":"347","author":"MS Fradin","year":"2002","unstructured":"Fradin MS, Day JF: Comparative efficacy of insect repellents against mosquito bites. N Engl J Med. 2002, 347: 13-18. 10.1056\/NEJMoa011699.","journal-title":"N Engl J Med"},{"key":"1577_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006657.pub2","volume-title":"Indoor residual spraying for preventing malaria","author":"B Pluess","year":"2010","unstructured":"Pluess B, Tanser FC, Lengeler C, Sharp BL: Indoor residual spraying for preventing malaria. Cochrane Database of Systematic Reviews. 2010, Art.No.:CD006657, Issue 4"},{"key":"1577_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1475-2875-9-67","volume":"9","author":"G Zhou","year":"2010","unstructured":"Zhou G, Githeko AK, Minakawa N, Yan G: Community-wide benefits of targeted indoor residual spray for malaria control in the Western Kenya Highland. Malar J. 2010, 9: 67-10.1186\/1475-2875-9-67.","journal-title":"Malar J"},{"key":"1577_CR30","doi-asserted-by":"publisher","first-page":"e2661","DOI":"10.1371\/journal.pone.0002661","volume":"3","author":"A Ross","year":"2008","unstructured":"Ross A, Penny M, Maire N, Studer A, Carneiro I, Schellenberg D, Greenwood B, Tanner M, Smith T: Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants. PLoS ONE. 2008, 3: e2661-10.1371\/journal.pone.0002661.","journal-title":"PLoS ONE"},{"key":"1577_CR31","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1086\/522160","volume":"196","author":"MP Grobusch","year":"2007","unstructured":"Grobusch MP, Lell B, Schwarz NG, Gabor J, D\u00f6rnemann J, P\u00f6tschke M, Oyakhirome S, Kiessling GC, Necek M, L\u00e4ngin MU, Klouwenberg PK, Kl\u00f6pfer A, Naumann B, Altun H, Agnandji ST, Goesch J, Decker M, Salazar CLO, Supan C, Kombila DU, Borchert L, K\u00f6ster L, Pongratz P, Adegnika AA, Glasenapp IV, Issifou S, Kremsner PG: Intermittent preventive treatment against malaria in infants in Gabon\u2014a randomized, double-blind, placebo-controlled trial. J Infect Dis. 2007, 196: 1595-1602. 10.1086\/522160.","journal-title":"J Infect Dis"},{"key":"1577_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1475-2875-8-292","volume":"8","author":"CK Ahorlu","year":"2009","unstructured":"Ahorlu CK, Koram KA, Seakey AK, Weiss MG: Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control. Malar J. 2009, 8: 292-10.1186\/1475-2875-8-292.","journal-title":"Malar J"},{"key":"1577_CR33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0166-6851(89)90203-X","volume":"36","author":"JA Lyon","year":"1989","unstructured":"Lyon JA, Thomas AW, Hall T, Chulay JD: Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes. Mol Biochem Parasitol. 1989, 36: 77-85. 10.1016\/0166-6851(89)90203-X.","journal-title":"Mol Biochem Parasitol"},{"key":"1577_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.193.12.F51","volume":"193","author":"A Saul","year":"2001","unstructured":"Saul A, Miller LH: A robust neutralization test for Plasmodium falciparum malaria. J Exp Med. 2001, 193: 51-54. 10.1084\/jem.193.12.F51.","journal-title":"J Exp Med"},{"key":"1577_CR35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4269\/ajtmh.1997.57.495","volume":"57","author":"Q Cheng","year":"1997","unstructured":"Cheng Q, Lawrence G, Reed C, Stowers A, Ranford-Cartwright L, Creasey A, Carter R, Saul A: Measurement of Plasmodium falciparum growth rate in vivo: a test of malaria vaccines. Am J Trop Med Hyg. 1997, 57: 495-500.","journal-title":"Am J Trop Med Hyg"},{"key":"1577_CR36","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1084\/jem.172.6.1633","volume":"172","author":"H Bouharoun-Tayoun","year":"1990","unstructured":"Bouharoun-Tayoun H, Attanah P, Sabchareon A, Chongsuphajaisiddhi T, Druilhe P: Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med. 1990, 172: 1633-1641. 10.1084\/jem.172.6.1633.","journal-title":"J Exp Med"},{"key":"1577_CR37","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/IAI.60.4.1473-1481.1992","volume":"60","author":"H Bouharoun-Tayoun","year":"1992","unstructured":"Bouharoun-Tayoun H, Druilhe P: Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun. 1992, 60: 1473-1481.","journal-title":"Infect Immun"},{"key":"1577_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/IAI.66.1.11-17.1998","volume":"66","author":"M Theisen","year":"1998","unstructured":"Theisen M, Soe S, Oeuvray C, Thomas A, Vuust J, Denielsen S, Jepsen S, Druile P: The Glutamate-Rich Protein (GLURP) of Plasmodium falciparumis a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro. Infect Immun. 1998, 66: 11-17.","journal-title":"Infect Immun"},{"key":"1577_CR39","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1086\/339342","volume":"185","author":"B Genton","year":"2002","unstructured":"Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L, Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP, Alpers MP: A recombinant blood-stage malaria vaccine reduces Plasmodium falciparumdensity and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis. 2002, 185: 820-827. 10.1086\/339342.","journal-title":"J Infect Dis"},{"key":"1577_CR40","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1016\/j.vaccine.2007.03.012","volume":"25","author":"ME Polhemus","year":"2007","unstructured":"Polhemus ME, Magill AJ, Cummings JF, Kester KE, Ockenhouse CF, Lanar DE, Dutta S, Barbosa A, Soisson L, Diggs CL, Robinson SA, Haynes JD, Stewart AV, Ware LA, Brando C, Krzych U, Bowden RA, Cohen JD, Dubois MC, Opokua OA: Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naive adults at the Walter Reed Army Institute of Research. Vaccine. 2007, 25: 4203-4212. 10.1016\/j.vaccine.2007.03.012.","journal-title":"Vaccine"},{"key":"1577_CR41","doi-asserted-by":"publisher","first-page":"e1465","DOI":"10.1371\/journal.pone.0001465","volume":"3","author":"MA Thera","year":"2008","unstructured":"Thera MA, Doumbo OK, Coulibaly D, Diallo DA, Kone AK, Guindo AB, Traore K, Sissoko M, Diallo DA, Diarra I, Kouiba B, Daou M, Dolo A, Baby M, Sissoko MS, Sagara I, Niangaly A, Traore I, Diawara SI, Owusu A, Nixon JN, Gregson A, Angov E, Stewart VA, Godeaux O, Leach A, Dubois MC, Bollou WR, Cohen J, Thomson D, Dube T, Soisson L, Diggs CL, Takala SL, Lyke KE, House B, Lanar DE, Dutta S, Heppner DG, Plowe CV: Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: Results of a phase 1 randomized controlled trial. PLoS ONE. 2008, 3: e1465-10.1371\/journal.pone.0001465.","journal-title":"PLoS ONE"},{"key":"1577_CR42","doi-asserted-by":"publisher","first-page":"e9041","DOI":"10.1371\/journal.pone.0009041","volume":"5","author":"MA Thera","year":"2010","unstructured":"Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Kone AK, Guindo AB, Traore K, Sissoko M, Diallo DA, Diarra I, Kouiba B, Daou M, Dolo A, Baby M, Sissoko MS, Sagara I, Niangaly A, Traore I, Olotu A, Godeaux O, Leach A, Dubois MC, Bollou WR, Cohen J, Thomson D, Dube T, Soisson L, Diggs CL, Takala SL, Lyke KE, House B, Lanar DE, Dutta S, Heppner DG, Plowe CV: Safety and Immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial. PLoS ONE. 2010, 5: e9041-10.1371\/journal.pone.0009041.","journal-title":"PLoS ONE"},{"issue":"Suppl 1","key":"1577_CR43","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1186\/1475-2875-7-S1-S10","volume":"7","author":"GA Targett","year":"2008","unstructured":"Targett GA, Greenwood BM: Malaria vaccines and their potential role in the elimination of malaria. Malar J. 2008, 7 (Suppl 1): S10-10.1186\/1475-2875-7-S1-S10.","journal-title":"Malar J"},{"key":"1577_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1365-3156.2003.00997.x","volume":"8","author":"SB Sirima","year":"2003","unstructured":"Sirima SB, Konat\u00e9 A, Tiono AB, Convelbo N, Cousens S, Pagnoni F: Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Tropical Medicine & International Health. 2003, 8: 133-139. 10.1046\/j.1365-3156.2003.00997.x.","journal-title":"Tropical Medicine & International Health"},{"key":"1577_CR45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S1473-3099(02)00372-9","volume":"2","author":"PJ Guerin","year":"2002","unstructured":"Guerin PJ, Olliaro P, Nosten F, Druilhe P, Laxminarayan R, Binka F, Kilama WL, Ford N, White NJ: Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis. 2002, 2: 564-573. 10.1016\/S1473-3099(02)00372-9.","journal-title":"Lancet Infect Dis"},{"key":"1577_CR46","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1086\/587645","volume":"197","author":"BI Karen","year":"2008","unstructured":"Karen BI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ: Increased gametocytemia after treatment: An early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. J Infect Dis. 2008, 197: 1605-1613. 10.1086\/587645.","journal-title":"J Infect Dis"},{"key":"1577_CR47","doi-asserted-by":"publisher","first-page":"e6352","DOI":"10.1371\/journal.pone.0006352","volume":"4","author":"DR Chowdhury","year":"2009","unstructured":"Chowdhury DR, Angov E, Kariuki T, Kumar N: A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48\/45 expressed in Escherichia coli. PLoS ONE. 2009, 4: e6352-10.1371\/journal.pone.0006352.","journal-title":"PLoS ONE"},{"key":"1577_CR48","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/S0264-410X(00)00521-1","volume":"19","author":"R Carter","year":"2001","unstructured":"Carter R: Transmission blocking malaria vaccines. Vaccine. 2001, 19: 2309-2314. 10.1016\/S0264-410X(00)00521-1.","journal-title":"Vaccine"},{"key":"1577_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/73062","volume":"6","author":"R Carter","year":"2000","unstructured":"Carter R, Mendis KN, Miller LH, Molineaux L, Saul A: Malaria transmission-blocking vaccines\u2014how can their development be supported?. Nature Med. 2000, 6: 241-244. 10.1038\/73062.","journal-title":"Nature Med"},{"key":"1577_CR50","doi-asserted-by":"publisher","first-page":"e1000324","DOI":"10.1371\/journal.pmed.1000324","volume":"7","author":"JT Griffin","year":"2010","unstructured":"Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M: Reducing Plasmodium falciparum malaria transmission in africa: a model-based evaluation of intervention strategies. PLoS Med. 2010, 7: e1000324-10.1371\/journal.pmed.1000324.","journal-title":"PLoS Med"},{"issue":"9","key":"1577_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/hv.9141","volume":"5","author":"R Chilengi","year":"2009","unstructured":"Chilengi R: Clinical development of malaria vaccines: should earlier trials be done in malaria endemic countries?. Human Vaccines. 2009, 5 (9): 1-10.","journal-title":"Human Vaccines"},{"key":"1577_CR52","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1475-2875-5-98","volume":"5","author":"MJAM Oesterholt","year":"2006","unstructured":"Oesterholt MJAM, Bousema JT, Mwerinde OK, Harris C, Lushino P, Masokoto A, Mwerinde H, Mosha FW, Drakeley CJ: Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania. Malar J. 2006, 5: 98-10.1186\/1475-2875-5-98.","journal-title":"Malar J"},{"key":"1577_CR53","doi-asserted-by":"publisher","first-page":"e6627","DOI":"10.1371\/journal.pone.0006627","volume":"4","author":"R \u00c1guas","year":"2009","unstructured":"\u00c1guas R, Louren\u00e7o JML, Gomes GMM, White LJ: The impact of IPTi and IPTc interventions on malaria clinical burden \u2013 in silico perspectives. PLoS ONE. 2009, 4: e6627-10.1371\/journal.pone.0006627.","journal-title":"PLoS ONE"},{"key":"1577_CR54","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","volume":"364","author":"PL Alonso","year":"2004","unstructured":"Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, Bassat Q, Aide P, Ofori-Anyinam O, Navia MM, Corachan S, Ceuppens M, Dubois M, Demoiti\u00e9 MA, Dubovsky F, Men\u00e9ndez C, Tornieporth N, Ballou WR, Thompson R, Cohen J: Efficacy of the RTS,S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004, 364: 1411-20. 10.1016\/S0140-6736(04)17223-1.","journal-title":"Lancet"},{"key":"1577_CR55","unstructured":"PATH Malaria Vaccine Initiative & Energetics Incorporated: Malaria Vaccine Technology Roadmap 2006. Accessed 25th March 2010, [ http:\/\/www.malariavaccineroadmap.net\/dfs\/Malaria_Vaccine_TRM_Final.pdf ]"},{"key":"1577_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1475-2875-6-72","volume":"6","author":"AA Amin","year":"2007","unstructured":"Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW: The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J. 2007, 6: 72-10.1186\/1475-2875-6-72.","journal-title":"Malar J"},{"key":"1577_CR57","doi-asserted-by":"publisher","first-page":"e1000183","DOI":"10.1371\/journal.pmed.1000183","volume":"7","author":"NA Szleza\u00c2\u00b4k","year":"2010","unstructured":"Szleza\u00c2\u00b4k NA, Bloom BR, Jamison DT, Keusch GT, Michaud CM, Moon S, Clark WC: The global health system: actors, norms, and expectations in transition. PLoS Medicine. 2010, 7: e1000183-10.1371\/journal.pmed.1000183.","journal-title":"PLoS Medicine"},{"key":"1577_CR58","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","volume":"367","author":"AD Lopez","year":"2006","unstructured":"Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet. 2006, 367: 1747-1757. 10.1016\/S0140-6736(06)68770-9.","journal-title":"Lancet"},{"key":"1577_CR59","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1371\/journal.pmed.0030473","volume":"3","author":"SI Hay","year":"2006","unstructured":"Hay SI, Snow RW: The malaria atlas project: developing global maps of malaria risk. PLoS Med. 2006, 3: e473-10.1371\/journal.pmed.0030473.","journal-title":"PLoS Med"},{"key":"1577_CR60","first-page":"1352","volume-title":"World Bank Publications","author":"DT Jamison","year":"2007","unstructured":"Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M: Disease control priorities in developing countries. World Bank Publications. 2007, 1352-"},{"key":"1577_CR61","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0140-6736(07)61700-0","volume":"370","author":"R Beaglehole","year":"2007","unstructured":"Beaglehole R, Ebrahim S, Reddy S: Prevention of chronic diseases: A call to action. Lancet. 2007, 370: 2152-2157. 10.1016\/S0140-6736(07)61700-0.","journal-title":"Lancet"},{"issue":"pt 3","key":"1577_CR62","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1017\/S0031182000080227","volume":"96","author":"TL Richie","year":"1988","unstructured":"Richie TL: Interactions between malaria parasites infecting the same vertebrate host. Parasitology. 1988, 96 (pt 3): 607-39. 10.1017\/S0031182000080227.","journal-title":"Parasitology"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-9-S3-S1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-9-S3-S1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-9-S3-S1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T10:47:05Z","timestamp":1592304425000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-9-S3-S1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":62,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-9-s3-s1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"article-number":"S1"}}